Tabla 2: Resultados clínicos.* |
|||||||
EVA |
Pre- operatorio |
Post- operatorio |
p |
|
|
|
|
Global |
7.5 ± 1.2 |
3.4 ± 2.1 |
0.0001 |
|
|
|
|
Enfermedad reumatoide |
7.7 ± 1.3 |
3 ± 1.9 |
0.36 |
|
|
|
|
No enfermedad reumatoide |
7 ± 2.8 |
3.5 ± 3.1 |
|
|
|
|
|
|
Global |
Enfermedad reumatoide |
No enfermedad reumatoide |
p |
Satisfacción |
p |
|
Sí |
No |
||||||
AOFAS |
|
|
|
|
|
|
|
Total (100) |
77.9 ± 10.2 |
76.9 ± 11.4 |
79.3 ± 12.5 |
0.23 |
79.9 ± 6.1 |
76.2 ± 7.1 |
0.024 |
Dolor (40) |
36.4 ± 8.9 |
36.5 ± 6.6 |
36.8 ± 10.7 |
0.28 |
37.1 ± 4.5 |
35.8 ± 4.1 |
|
Función (45) |
28.5 ± 7.2 |
27.6 ± 8.1 |
31.9 ± 9.8 |
0.21 |
29.3 ± 3.3 |
27.7 ± 3.6 |
|
Alineación (15) |
13.1 ± 4.7 |
12.8 ± 4.2 |
13.2 ± 6.7 |
0.36 |
13.5 ± 2.7 |
12.7 ± 3.3 |
|
MOxFQ |
|
|
|
|
|
|
|
Total |
18.3 ± 8.3 |
19 ± 9.4 |
17.1 ± 10.8 |
0.32 |
15.3 ± 5.2 |
33.1 ± 3.9 |
0.02 |
* Los datos indican la media ± desviación estándar. EVA = escala visual analógica. AOFAS = American Orthopaedic Foot and Ankle Society. MOxFQ = Manchester-Oxford Foot Questionnaire. |